Back to top

earnings-outlook: Archive

Zacks Equity Research

Petrobras (PBR) Upgraded to Strong Buy: Here's Why

Petrobras (PBR) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #1 (Strong Buy).

PBRNegative Net Change

Zacks Equity Research

What Makes ASM International (ASMIY) a New Strong Buy Stock

ASM International (ASMIY) has been upgraded to a Zacks Rank #1 (Strong Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

ASMIYPositive Net Change

Zacks Equity Research

Suncor Energy (SU) Upgraded to Buy: Here's Why

Suncor Energy (SU) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

SUNegative Net Change

Zacks Equity Research

Ecopetrol (EC) Upgraded to Buy: Here's Why

Ecopetrol (EC) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

ECNegative Net Change

Zacks Equity Research

What Makes Marex Group PLC (MRX) a New Strong Buy Stock

Marex Group PLC (MRX) has been upgraded to a Zacks Rank #1 (Strong Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

MRXNegative Net Change

Zacks Equity Research

Minerals Technologies (MTX) Upgraded to Buy: Here's Why

Minerals Technologies (MTX) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).

MTXPositive Net Change

Zacks Equity Research

Chevron (CVX) Upgraded to Buy: Here's What You Should Know

Chevron (CVX) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

CVXNegative Net Change

Zacks Equity Research

Xilio Therapeutics (XLO) Upgraded to Buy: What Does It Mean for the Stock?

Xilio Therapeutics (XLO) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

XLOPositive Net Change

Zacks Equity Research

Otter Tail (OTTR) Upgraded to Buy: Here's Why

Otter Tail (OTTR) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).

OTTRPositive Net Change

Zacks Equity Research

All You Need to Know About Idaho Strategic Resources (IDR) Rating Upgrade to Strong Buy

Idaho Strategic Resources (IDR) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #1 (Strong Buy).

IDRPositive Net Change